Dossier
Sublocade
Coverage of Sublocade in the Nexus archive.
- ‘Life-saving’ drug for people with opioid dependency to be pulled from Australia by end of year
A 'life-saving' drug for opioid dependency, Sublocade, will be withdrawn from Australia by the end of the year due to a commercial decision by US pharmaceutical company Indivior, causing concern among doctors and pharmacists.
- Randolph hospital offers extended-release opioid treatment in emergency department
Gifford Medical Center in Randolph, Vermont, is the first hospital in the state to offer Sublocade, an extended-release buprenorphine injection for opioid use disorder, through its emergency department and inpatient units. The treatment, administered weekly, aims to improve accessibility by eliminating daily dosing and offering 24/7 availability.